Bora Pharmaceuticals Co., LTD. (TPE:6472)
Taiwan
· Delayed Price · Currency is TWD 675.00
-46.00 (-6.38%)
Mar 31, 2025, 1:30 PM CST
TPE:6472 Revenue
In the year 2024, Bora Pharmaceuticals Co., LTD. had annual revenue of 19.25B TWD with 35.53% growth. Bora Pharmaceuticals Co., LTD. had revenue of 5.75B in the quarter ending December 31, 2024, with 79.26% growth.
Revenue
19.25B
Revenue Growth
+35.53%
P/S Ratio
3.57
Revenue / Employee
n/a
Employees
n/a
Market Cap
69.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.25B | 5.05B | 35.53% |
| Dec 31, 2023 | 14.20B | 3.71B | 35.31% |
| Dec 31, 2022 | 10.49B | 5.59B | 114.18% |
| Dec 31, 2021 | 4.90B | 3.10B | 172.28% |
| Dec 31, 2020 | 1.80B | 270.35M | 17.68% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Polaris Group | 107.00M |
| Center Laboratories | 1.62B |